✉news HealthMedicine first seen 1 d ago, last 1 d ago, peak #16
VA and Pentagon Guideline Backs Semaglutide and Tirzepatide for Obesity
Original: New VA/DoD Obesity Guideline Strongly Recommends Semaglutide, Tirzepatide
The Department of Veterans Affairs and Department of Defense have issued a new obesity guideline that strongly recommends GLP-1 medications semaglutide and tirzepatide for weight management in veterans and service members. The recommendation is drawing attention because it signals growing official acceptance of newer weight-loss drugs and could influence care for millions of patients across the military health system.
Why now: The strong federal endorsement of high-profile weight-loss drugs matters for millions of veterans, troops and healthcare costs.
Department of Veterans AffairsDepartment of Defensesemaglutidetirzepatide
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1316399